Institute of Molecular Biotechnology
| Established | 1999 |
|---|---|
Laboratory type | Basic life science research institute |
Field of research | Molecular biology, regeneration, organoids and stem cells |
| Directors | Elly Tanaka (scientific), Barbara Kraus (business) |
| Faculty | 15 |
| Staff | 250 |
| Location | Dr.-Bohr-Gasse 3, Vienna, Austria |
| Campus | Vienna BioCenter |
| Affiliations | Austrian Academy of Sciences, Vienna BioCenter |
| Website | https://www.imba.oeaw.ac.at/ |
The Institute of Molecular Biotechnology (IMBA) is a biomedical research organisation of the Austrian Academy of Sciences, founded in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.